FindMyKOL
Clinical trialNCT00028132CompletedPhase 1Interventional

Safety and Acceptability of the Anti-Microbe Vaginal Gel, PMPA Gel

SponsorNational Institute of Allergy and Infectious Diseases (NIAID)Enrollment120HIV Infections
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

The purpose of this study is to evaluate the PMPA gel, which kills microbes, in HIV-infected and HIV-uninfected women. The majority of new HIV infections occur through heterosexual contact. A product that stops or slows the replication of HIV during sexual contact is needed. At present, there are no products that are completely effective. PMPA gel, also known as tenofovir, is an anti-microbe agent that may fight against sexual transmission of HIV and other sexually transmitted diseases (STDs). It is applied to the vagina and gives women the ability to control their disease-prevention activity.

Investigators

The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

5 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Harlem Prevention Ctr. Crs (el-Sadr Ctu)

    New York, New York, United States

  • Bronx- Lebanon Hospital Center Clinical Research Site (blhc Crs)

    The Bronx, New York, United States

  • 3535 Market Street Crs

    Philadelphia, Pennsylvania, United States

  • the Miriam Hosp., Div. of Infectious Disease

    Providence, Rhode Island, United States

  • Women & Infants' Hosp.

    Providence, Rhode Island, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

Tenofovir
Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
—
Primary completion
—
Completion
31 Dec 2005
Last update posted
1 Nov 2021
Registered enrollment
120
Registry id
NCT00028132

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 11 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.